Skip to content

Changweishu capsule in the treatment of spleen and stomach damp-heat syndrome

Changweishu capsule in the treatment of spleen and stomach damp-heat syndrome

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016605
Enrollment
Unknown
Registered
2018-06-11
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

damp heat in the spleen and the stomach

Interventions

treatment group of astriction:capsule of Changweishu
control group of astriction:capsule of Marenrunchang
treatment group of diarrhea:capsule of Changweishu
control group of diarrhea:tablet of Xianglian

Sponsors

Dongzhimen hospital affilisted to Beijing university of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Confirmed by histopathology or cytology as a cancer patient; 2. Conforms to the diagnostic criteria of spleen and stomach damp-heat syndrome; 3. Outpatients or inpatients aged over 18 years old, but outpatients must be able to visit the hospital on time according to the program requirements; 4. During the treatment period, other drugs for treating spleen and stomach damp-heat syndrome including decoction were not used; 5. Patients whose survival period is more than 3 months.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary heart, brain, liver, kidney, and hematopoietic diseases, or with severe tumor complications and comorbidities, or those with severe liver and kidney injury; 2. Participating in other clinical practice; 3. Women of Pregnancy and lactation; 4. Allergies or persons known to be allergic to certain drugs in the prescription; 5. Intestinal stenosis caused by rectal and colon organic lesions (such as tumors, Crohn's disease, colon polyps, intestinal tuberculosis, etc.), or local lesions (large ascites, diaphragmatic paralysis, etc.) leading to constipation; Acute ileus; 6. Patients with psychiatric or cognitive disorders; 7. Can not be on time medication, poor compliance or can not adhere to the follow-up.

Design outcomes

Primary

MeasureTime frame
TCM syndrome;

Countries

China

Contacts

Public ContactChen Xinyi

Dongzhimen hospital affilisted to Beijing university of Chinese Medicine

chenxinyi0729@126.com+86 13601008250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026